Bank of Montreal
VKTX icon

Bank of Montreal’s Viking Therapeutics VKTX Stock Holding History

Bank of Montreal’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-35,252
Closed -$2.17M – 3961
2024
Q3 		$2.17M Buy
35,252
+29,819
+549% +$1.75M ﹤0.01% 1670
2024
Q2 		$288K Sell
5,433
-11,050
-67% -$724K ﹤0.01% 2761
2024
Q1 		$1.36M Buy
+16,483
New +$733K ﹤0.01% 1832
2022
Q3 		– Sell
-285,319
Closed -$826 – 4432
2022
Q2 		$826 Buy
+285,319
New +$706K ﹤0.01% 2428
2021
Q4 		– Sell
-126,642
Closed -$849K – 3908
2021
Q3 		$849K Sell
126,642
-17,065
-12% -$105K ﹤0.01% 2587
2021
Q2 		$896K Buy
143,707
+48,203
+50% +$286K ﹤0.01% 2553
2021
Q1 		$587K Sell
95,504
-36,992
-28% -$260K ﹤0.01% 2543
2020
Q4 		$889K Buy
132,496
+6,549
+5% +$39.7K ﹤0.01% 2323
2020
Q3 		$739K Sell
125,947
-15,743
-11% -$108K ﹤0.01% 2129
2020
Q2 		$975K Buy
141,690
+13,637
+11% +$90.6K ﹤0.01% 1935
2020
Q1 		$575K Sell
128,053
-276,087
-68% -$1.7M ﹤0.01% 1916
2019
Q4 		$3.24M Buy
404,140
+330,045
+445% +$2.41M ﹤0.01% 1608
2019
Q3 		$510K Buy
74,095
+2,688
+4% +$20K ﹤0.01% 2407
2019
Q2 		$593K Sell
71,407
-5,232
-7% -$44.7K ﹤0.01% 2324
2019
Q1 		$761K Buy
76,639
+20,600
+37% +$172K ﹤0.01% 2123
2018
Q4 		$430K Buy
56,039
+11,796
+27% +$141K ﹤0.01% 2235
2018
Q3 		$771K Sell
44,243
-16,901
-28% -$201K ﹤0.01% 2122
2018
Q2 		$580K Buy
+61,144
New +$407K ﹤0.01% 2266

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Bank of Montreal's VKTX Position: Q4 2024 in Review

Bank of Montreal sold out of Viking Therapeutics (VKTX) in Q4 2024, closing a stake of 35,252 shares — an estimated $2.17M sold.

Bank of Montreal first reported a position in VKTX in Q2 2018 and held it in 18 quarters. The position peaked at $3.24M in Q4 2019. 408 funds tracked by Wall St. Rank hold VKTX as of Q4 2024.

  • Bank of Montreal reported no remaining Viking Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Bank of Montreal sold 35,252 Viking Therapeutics shares in Q4 2024, an estimated $2.17M.
  • Bank of Montreal first reported a position in Viking Therapeutics in Q2 2018 and held it in 18 quarters.
  • Bank of Montreal's Viking Therapeutics position peaked at $3.24M in Q4 2019.
  • 408 funds tracked by Wall St. Rank held Viking Therapeutics as of Q4 2024.

Based on Bank of Montreal's 13F filing for Q4 2024, filed 13 Feb 2025.